Head and Neck Imaging
Application of MRI Combined with Tumor Markers in the Diagnosis of Prostatic Cancer
Author：ZHANG Yan-jun, DING De-gang, ZHAO Wei-hua
affiliation：Department of Urology, Zhengzhou Coal Industry (Group) co., LTD General Hospital, Xinmi 452371, Henan Province, China
PDFAbstract
Objective To explore the clinical application of magnetic resonance imaging (MRI) combined with tumor markers in the diagnosis of prostatic cancer (PCa). Methods The clinical data of 86 patients with prostatic cancer were analyzed retrospectively. According to the results of histological biopsy and benign and malignant condition, the patients were divided into PCa group (n=35) and benign prostatic hyperplasia (BPH) group (n=51). All patients were detected by MRI and serum prostate specific antigen (PSA), and the levels of PSA related indicators were compared between the two groups, and differences in diagnostic accuracy of simple PSA, or MRI detection and the two combination were analyzed. Results There were significant differences in the levels of PSA related indicators between the two groups (all P<0.05). The diagnostic coincidence rate of MRI combined with PSA was 93.02% (80/86) in the detection of PCa, which was significantly higher than that of the two simple detection methods (all P<0.05). Conclusion MRI combined with tumor markers has high accuracy in the diagnosis of PCa, and it has a good prospect in clinical application.
【Keyword】Magnetic Resonance Imaging; Tumor Markers; Prostatic Cancer
【Chart number】R737.25
【Document Identification Number】A
【DOI】 10.3969/j.issn.1672- 5131.2018.07.037
Chinese journal of CT and MRI
th16Volume， th 7 Issue
2018Year07Month
Related articles
Editor email：（1）中国CT和MRI杂志：ctmri@vip.163.com；（2）罕少疾病杂志：hs1999@vip.163.com
Contact number：0755-83695203
Our address：
English
简体中文
logged in
Wechat
TouTiao